Mexican Patent Office excludes Formulation Patents from Linkage Gazette
POR ALEJANDRO LUNA SOCIO PATENT DOCS, 2010 On Friday, August 13, 2010, the Mexican Trademark and Patent Office (IMPI) made available through its website the new edition of the Linkage Gazette (Mexican health and IP law regulations require IMPI to publish a gazette every six months listing patents in force that cover allopathic drugs). Regrettably, IMPI[...]
Read More
The International Comparative Legal Guide to: Merger Control 2011
POR GUSTAVO ALCOCER SOCIO Y CARLOS WOODWORTH M. ICLG TO: MERGER CONTROL 2011, CHAPTER 28 MEXICO 1. RELEVANT AUTHORITIES AND LEGISLATION 1.1. WHO IS/ARE THE RELEVANT MERGER AUTHORITY (IES)? The Federal Competition Commission, which is an administrative agency independent from the Mexican Ministry of Economy, has technical and operational autonomy to issue its resolutions. The Commission is[...]
Read More
Mexico gets ready to approve biocomparable drugs
POR ALEJANDRO LUNA Y JUAN LUIS SERRANO LIFE SCIENCE IP FOCUS, 8TH EDITION, MANAGING INTELLECTUAL PROPERTY 2010 MEXICO’S DRUG REGULATORS ARE PREPARING TO ISSUE NEW RULES ON BIOCOMPARABLE DRUGS. Mexico’s General Health Law was reformed on June 11 2009 in ways that will have an important impact on patent owners within the pharmaceutical and life sciences industries.[...]
Read More
Reform of preliminary injunctions
POR ARMANDO ARENAS INTERNATIONAL BRIEFINGS, MANAGING INTELLECTUAL PROPERTY, OCTOBER 2010 According to the current wording of the Mexican IP Law, injunctions can be imposed during the course of an infringement action related to trademarks, patents or slogans, and the plaintiff has to post a bond of an amount fixed by the Patent of Trade Mark Office[...]
Read More